These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study]. de Carsalade GY, Achirafi A, Flageul B. Acta Leprol; 2003 Jul; 12(3):117-22. PubMed ID: 15040702 [Abstract] [Full Text] [Related]
4. Serum zinc/copper ratio in subtypes of leprosy and effect of oral zinc therapy on reactional states. George J, Bhatia VN, Balakrishnan S, Ramu G. Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):20-4. PubMed ID: 2030313 [Abstract] [Full Text] [Related]
5. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia. Becx-Bleumink M, Berhe D. Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359 [Abstract] [Full Text] [Related]
6. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide. Feuth M, Brandsma JW, Faber WR, Bhattarai B, Feuth T, Anderson AM. Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975 [Abstract] [Full Text] [Related]
7. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum. Verma KK, Srivastava P, Minz A, Verma K. Lepr Rev; 2006 Sep; 77(3):225-9. PubMed ID: 17172003 [Abstract] [Full Text] [Related]
8. Risk factors for erythema nodosum leprosum. Manandhar R, LeMaster JW, Roche PW. Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406 [Abstract] [Full Text] [Related]
9. Pulsed corticosteroid therapy in patients with chronic recurrent ENL: a pilot study. Girdhar A, Chakma JK, Girdhar BK. Indian J Lepr; 2002 Sep; 74(3):233-6. PubMed ID: 12708702 [Abstract] [Full Text] [Related]
11. Daily multidrug therapy for leprosy; results of a fourteen-year experience. de Carsalade GY, Wallach D, Spindler E, Pennec J, Cottenot F, Flageul B. Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752 [Abstract] [Full Text] [Related]
12. Pentoxifylline in the treatment of erythema nodosum leprosum. De Carsalade GY, Achirafi A, Flageul B. J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712 [Abstract] [Full Text] [Related]
13. Treatment of recurrent erythema nodosum leprosum with infliximab. Faber WR, Jensema AJ, Goldschmidt WF. N Engl J Med; 2006 Aug 17; 355(7):739. PubMed ID: 16914716 [No Abstract] [Full Text] [Related]
15. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum. Rea TH, Sieling PA. Int J Lepr Other Mycobact Dis; 1998 Sep 17; 66(3):316-27. PubMed ID: 9934358 [Abstract] [Full Text] [Related]
16. Some unusual type 2 reactions in leprosy. Ramesh V, Pahwa M. Int J Dermatol; 2010 Feb 17; 49(2):172-5. PubMed ID: 20465641 [Abstract] [Full Text] [Related]
18. Erythema leprosum--after treatment of Lepromatous Leprosy. Eickelmann M, Steinhoff M, Metze D, Tomimori-Yamashita J, Sunderkötter C. J Dtsch Dermatol Ges; 2010 Jun 17; 8(6):450-3. PubMed ID: 19922466 [Abstract] [Full Text] [Related]
19. Erythema nodosum leprosum in subgroups of lepromatous leprosy. Bhargava P, Kuldeep CM, Mathur NK. Lepr Rev; 1997 Dec 17; 68(4):373-5. PubMed ID: 9503874 [No Abstract] [Full Text] [Related]
20. Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum. Foss NT, de Oliveira EB, Silva CL. Int J Lepr Other Mycobact Dis; 1993 Jun 17; 61(2):218-26. PubMed ID: 8371031 [Abstract] [Full Text] [Related] Page: [Next] [New Search]